Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Q: What does CUSIP 30050B101 represent in this 13F holders report?

CUSIP 30050B101 is the security identifier for EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in Q2 2020?

127 institutional investors reported EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 30050B101

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding: 112,318,617
Total 13F shares: 73,419,664
Share change: -2,360,376
Total reported value: $521,944,449
Put/Call ratio: 141%
Price per share: $7.12
Number of holders: 127
Value change: -$8,509,221
Number of buys: 64
Number of sells: 73

Quarterly Holders Quick Answers

What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 30050B101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	6.3%	7,091,100	$38,505,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	5.8%	6,485,842	$35,219,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	5.1%	5,687,377	$30,882,000	—	31 Mar 2020	13F
Bellevue Group AG	13F	Company	4.1%	4,580,458	$24,872,000	—	31 Mar 2020	13F
GLENMEDE TRUST CO NA	13F	Company	2%	2,297,012	$20,787,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.4%	3,814,741	$20,715,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	3.3%	3,743,238	$20,326,000	—	31 Mar 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	2.8%	3,138,860	$17,044,000	—	31 Mar 2020	13F
RIVERBRIDGE PARTNERS LLC	13F	Company	2.3%	2,550,050	$13,847,000	—	31 Mar 2020	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	2.2%	2,492,948	$11,966,150	—	31 Mar 2020	13F
Aberdeen Group plc	13F	Company	1.9%	2,146,329	$11,601,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	1.8%	1,974,585	$10,722,000	—	31 Mar 2020	13F
Elk Creek Partners, LLC	13F	Company	1.7%	1,944,309	$10,558,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	1.6%	1,783,872	$9,686,000	—	31 Mar 2020	13F
FORMULA GROWTH LTD	13F	Company	1.5%	1,694,025	$9,199,000	—	31 Mar 2020	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	1.4%	1,570,277	$8,527,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.3%	1,470,988	$7,988,000	—	31 Mar 2020	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.2%	1,345,672	$7,307,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.1%	1,275,767	$6,927,000	—	31 Mar 2020	13F
Granahan Investment Management, LLC	13F	Company	1.1%	1,236,082	$6,712,000	—	31 Mar 2020	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	1.1%	1,204,981	$6,543,000	—	31 Mar 2020	13F
GABELLI FUNDS LLC	13F	Company	1%	1,157,500	$6,285,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.98%	1,096,657	$5,955,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.94%	1,060,322	$5,757,000	—	31 Mar 2020	13F
DC Investments Management, LLC	13F	Company	0.9%	1,005,300	$5,459,000	—	31 Mar 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.84%	942,701	$5,119,000	—	31 Mar 2020	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.8%	903,756	$4,907,000	—	31 Mar 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.76%	851,269	$4,622,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.69%	770,451	$4,184,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.68%	759,128	$4,122,000	—	31 Mar 2020	13F
Rock Point Advisors, LLC	13F	Company	0.67%	747,313	$4,058,000	—	31 Mar 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	0.47%	533,411	$2,896,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.45%	501,500	$2,723,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.42%	472,126	$2,564,000	—	31 Mar 2020	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.42%	470,629	$2,556,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.42%	468,600	$2,544,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.34%	387,070	$2,102,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.33%	370,468	$2,012,000	—	31 Mar 2020	13F
IMA Advisory Services, Inc.	13F	Company	0.32%	359,416	$1,952,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.28%	318,724	$1,730,000	—	31 Mar 2020	13F
GAMCO INVESTORS, INC. ET AL	13F	Company	0.28%	313,003	$1,700,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.24%	271,486	$1,474,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.21%	231,027	$1,254,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.2%	224,284	$1,217,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.18%	203,510	$1,105,000	—	31 Mar 2020	13F
Allianz Asset Management GmbH	13F	Company	0.16%	182,866	$993,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.15%	169,713	$921,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.15%	165,063	$897,000	—	31 Mar 2020	13F
OPPENHEIMER ASSET MANAGEMENT INC.	13F	Company	0.15%	164,107	$891,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.14%	162,369	$882,000	—	31 Mar 2020	13F

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2020

As of 30 Jun 2020, Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,419,664 shares. The largest 10 holders included VANGUARD GROUP INC, JPMORGAN CHASE & CO, BlackRock Inc., Bellevue Group AG, DIMENSIONAL FUND ADVISORS LP, CREDIT SUISSE AG/, EAGLE ASSET MANAGEMENT INC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, BLAIR WILLIAM & CO/IL, and CARILLON TOWER ADVISERS, INC.. This page lists 127 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

144

Q2 2020 holders

127

Holder diff

-17

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.